Literature DB >> 28066057

THE RENIN-ANGIOTENSIN SYSTEM AND THE BIOLOGY OF SKELETAL MUSCLE: MECHANISMS OF MUSCLE WASTING IN CHRONIC DISEASE STATES.

Patrice Delafontaine, Tadashi Yoshida.   

Abstract

Sarcopenia and cachexia are muscle-wasting syndromes associated with aging and with many chronic diseases such as congestive heart failure, diabetes, cancer, chronic obstructive pulmonary disease, and renal failure. While mechanisms are complex, these conditions are often accompanied by elevated angiotensin II (Ang II). We found that Ang II infusion in rodents leads to skeletal muscle wasting via alterations in insulin-like growth factor-1 signaling, increased apoptosis, enhanced muscle protein breakdown via the ubiquitin-proteasome system, and decreased appetite resulting from downregulation of hypothalamic orexigenic neuropeptides orexin and neuropeptide Y. Furthermore, Ang II inhibits skeletal muscle stem cell proliferation, leading to lowered muscle regenerative capacity. Distinct stem cell Ang II receptor subtypes are critical for regulation of muscle regeneration. In ischemic mouse congestive heart failure model skeletal muscle wasting and attenuated muscle regeneration are Ang II dependent. These data suggest that the renin-angiotensin system plays a critical role in mechanisms underlying cachexia in chronic disease states.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28066057      PMCID: PMC5216488     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  50 in total

1.  Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study.

Authors:  Stefan D Anker; Abdissa Negassa; Andrew J S Coats; Rizwan Afzal; Philip A Poole-Wilson; Jay N Cohn; Salim Yusuf
Journal:  Lancet       Date:  2003-03-29       Impact factor: 79.321

2.  Reactive oxygen species stimulate insulin-like growth factor I synthesis in vascular smooth muscle cells.

Authors:  P Delafontaine; L Ku
Journal:  Cardiovasc Res       Date:  1997-01       Impact factor: 10.787

3.  IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression.

Authors:  Tadashi Yoshida; Laura Semprun-Prieto; Sergiy Sukhanov; Patrice Delafontaine
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-03-12       Impact factor: 4.733

4.  Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care--correlations with food intake, metabolism, exercise capacity, and hormones.

Authors:  Marita Fouladiun; Ulla Körner; Ingvar Bosaeus; Peter Daneryd; Anders Hyltander; Kent G Lundholm
Journal:  Cancer       Date:  2005-05-15       Impact factor: 6.860

5.  Skeletal muscle wasting in tumor-bearing rats is associated with MyoD down-regulation.

Authors:  P Costelli; M Muscaritoli; M Bossola; R Moore-Carrasco; S Crepaldi; G Grieco; R Autelli; G Bonelli; F Pacelli; F J Lopez-Soriano; J M Argilés; G B Doglietto; F M Baccino; F Rossi Fanelli
Journal:  Int J Oncol       Date:  2005-06       Impact factor: 5.650

Review 6.  The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress.

Authors:  Camila Manrique; Guido Lastra; Michael Gardner; James R Sowers
Journal:  Med Clin North Am       Date:  2009-05       Impact factor: 5.456

7.  Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production.

Authors:  Florian L Muller; Wook Song; Youngmok C Jang; Yuhong Liu; Marian Sabia; Arlan Richardson; Holly Van Remmen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-06-20       Impact factor: 3.619

8.  Angiotensin II receptor blockade administered after injury improves muscle regeneration and decreases fibrosis in normal skeletal muscle.

Authors:  Hany S Bedair; Tharun Karthikeyan; Andres Quintero; Yong Li; Johnny Huard
Journal:  Am J Sports Med       Date:  2008-06-11       Impact factor: 6.202

9.  One-year prevalence, comorbidities and cost of cachexia-related inpatient admissions in the USA.

Authors:  Susan Tsivitse Arthur; Joshua M Noone; Bryce A Van Doren; Debosoree Roy; Christopher M Blanchette
Journal:  Drugs Context       Date:  2014-07-31

10.  S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase.

Authors:  Victor Aguilar; Samira Alliouachene; Athanassia Sotiropoulos; Andrew Sobering; Yoni Athea; Fatima Djouadi; Sylvain Miraux; Eric Thiaudière; Marc Foretz; Benoit Viollet; Philippe Diolez; Jean Bastin; Paule Benit; Pierre Rustin; David Carling; Marco Sandri; Renée Ventura-Clapier; Mario Pende
Journal:  Cell Metab       Date:  2007-06       Impact factor: 27.287

View more
  11 in total

Review 1.  New insights into the pathogenesis and treatment of sarcopenia in chronic heart failure.

Authors:  Jiayu Yin; Xiang Lu; Zhiyuan Qian; Weiting Xu; Xiang Zhou
Journal:  Theranostics       Date:  2019-05-31       Impact factor: 11.556

2.  Angiotensin II receptor blockade is associated with preserved muscle strength in chronic hemodialysis patients.

Authors:  Yu-Li Lin; Shu-Yuan Chen; Yu-Hsien Lai; Chih-Hsien Wang; Chiu-Huang Kuo; Hung-Hsiang Liou; Bang-Gee Hsu
Journal:  BMC Nephrol       Date:  2019-02-14       Impact factor: 2.388

Review 3.  Role of comorbidities in heart failure prognosis Part 2: Chronic kidney disease, elevated serum uric acid.

Authors:  Andrea Tedeschi; Piergiuseppe Agostoni; Beatrice Pezzuto; Ugo Corra'; Domenico Scrutinio; Rocco La Gioia; Rosa Raimondo; Andrea Passantino; Massimo F Piepoli
Journal:  Eur J Prev Cardiol       Date:  2020-12       Impact factor: 7.804

Review 4.  Cancer-Associated Muscle Wasting-Candidate Mechanisms and Molecular Pathways.

Authors:  Victoria S Armstrong; Liam W Fitzgerald; Oliver F Bathe
Journal:  Int J Mol Sci       Date:  2020-12-04       Impact factor: 5.923

5.  Associations between homocysteine, inflammatory cytokines and sarcopenia in Chinese older adults with type 2 diabetes.

Authors:  Zhi-Jing Mu; Jun-Ling Fu; Li-Na Sun; Piu Chan; Shuang-Ling Xiu
Journal:  BMC Geriatr       Date:  2021-12-15       Impact factor: 3.921

6.  Angiotensin-II Drives Human Satellite Cells Toward Hypertrophy and Myofibroblast Trans-Differentiation by Two Independent Pathways.

Authors:  Annunziatina Laurino; Valentina Spinelli; Manuela Gencarelli; Valentina Balducci; Leonardo Dini; Lorenzo Diolaiuti; Marco Ghionzoli; Antonio Messineo; Alessandro Mugelli; Elisabetta Cerbai; Laura Raimondi; Laura Sartiani
Journal:  Int J Mol Sci       Date:  2019-10-03       Impact factor: 5.923

Review 7.  Sarcopenia and Heart Failure.

Authors:  Francesco Curcio; Gianluca Testa; Ilaria Liguori; Martina Papillo; Veronica Flocco; Veronica Panicara; Gianluigi Galizia; David Della-Morte; Gaetano Gargiulo; Francesco Cacciatore; Domenico Bonaduce; Francesco Landi; Pasquale Abete
Journal:  Nutrients       Date:  2020-01-14       Impact factor: 5.717

Review 8.  SARS-CoV-2/Renin-Angiotensin System: Deciphering the Clues for a Couple with Potentially Harmful Effects on Skeletal Muscle.

Authors:  Andrea Gonzalez; Josué Orozco-Aguilar; Oscar Achiardi; Felipe Simon; Claudio Cabello-Verrugio
Journal:  Int J Mol Sci       Date:  2020-10-24       Impact factor: 5.923

Review 9.  The Tissue Renin-Angiotensin System and Its Role in the Pathogenesis of Major Human Diseases: Quo Vadis?

Authors:  Babak Saravi; Zhen Li; Corinna N Lang; Bonaventura Schmid; Frauke K Lang; Sibylle Grad; Mauro Alini; Robert Geoffrey Richards; Hagen Schmal; Norbert Südkamp; Gernot M Lang
Journal:  Cells       Date:  2021-03-15       Impact factor: 6.600

Review 10.  Covid-19 and the Renin Angiotensin System: Implications for the Older Adults.

Authors:  G Bahat
Journal:  J Nutr Health Aging       Date:  2020       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.